Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-002053
Filing Date
2018-01-25
Accepted
2018-01-25 20:42:08
Documents
2
Period of Report
2018-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3410
2 EX-24 DOCUMENT attachment1.htm EX-24 3179
  Complete submission text file 0000899243-18-002053.txt   7965
Mailing Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RESTORBIO, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address
Mannick Joan (Reporting) CIK: 0001727384 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38359 | Film No.: 18549683